Genfit S.A. (EPA: GNFT)
France
· Delayed Price · Currency is EUR
4.060
+0.040 (1.00%)
Nov 22, 2024, 5:35 PM CET
Genfit Employees
Genfit had 159 employees as of December 31, 2023. The number of employees increased by 11 or 7.43% compared to the previous year.
Employees
159
Change (1Y)
11
Growth (1Y)
7.43%
Revenue / Employee
€476,178
Profits / Employee
€131,781
Market Cap
202.44M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
EssilorLuxottica Société anonyme | 151,292 |
Eurofins Scientific SE | 61,798 |
Ipsen S.A. | 5,325 |
ABIVAX Société Anonyme | 61 |
MedinCell S.A. | 134 |
Eurobio Scientific Société anonyme | 300 |
Inventiva S.A. | 123 |
Nanobiotix S.A. | 102 |
Genfit News
- 9 days ago - GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024 - GlobeNewsWire
- 15 days ago - Genfit reports 9M results - Seeking Alpha
- 15 days ago - GENFIT Reports Third Quarter 2024 Financial Information - GlobeNewsWire
- 2 months ago - Top 4 Health Care Stocks That May Keep You Up At Night - Benzinga
- 2 months ago - GENFIT: Ipsen's Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval - GlobeNewsWire
- 2 months ago - Genfit GAAP EPS of €0.53, revenue of €61.2M - Seeking Alpha
- 4 months ago - GENFIT: Positive Opinion from EMA Committee for Ipsen's Iqirvo® (elafibranor) in Primary Biliary Cholangitis - GlobeNewsWire
- 4 months ago - GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial - GlobeNewsWire